#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Factor VIII deficiency Hyperinsulinaemic hypoglycaemia Synovial sarcoma Neuroblastoma Mantle cell lymphoma stage II Pleomorphic liposarcoma Leukocyte adhesion deficiency Idiopathic intracranial hypertension Ependymoma Allogenic stem cell transplantation Leiomyosarcoma recurrent Superficial vein thrombosis Cardiac amyloidosis Rheumatoid arthritis Arrhythmogenic right ventricular dysplasia More trials…

    Learn about Rare Diseases

    Kearns-Sayre syndrome – Treatment Osteosarcoma metastatic – Basic Information Rhabdomyosarcoma Short-bowel syndrome Castleman’s disease Hereditary hypophosphataemic rickets – Treatment SAPHO syndrome Ewing’s sarcoma recurrent – Trials in Disease Osteosarcoma – Treatment Lymphangioma – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Mantle cell lymphoma stage III Lymphocytic lymphoma Lymphangioleiomyomatosis Embolism venous Pancreatic carcinoma Inner ear disorder Metastatic malignant melanoma Hypochromic anaemia Rhinitis allergic Systemic scleroderma Orthostatic hypotension Chronic hepatitis C Intermittent claudication Hepatocellular carcinoma Fibromyalgia More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Neoplasms

  • Study Comparing Pembrolizumab and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Brentuximab Vedotin
    • Pembrolizumab
    Czechia France Germany Italy Poland Sweden

  • Long-term Safety Study of Daratumumab with Drug Combination for Patients with Multiple Myeloma or Smoldering Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Lenalidomide
    • Daratumumab
    • Dexamethasone Sodium Phosphate
    Belgium Czechia Denmark France Germany Greece +3

  • Study of Linperlisib for Patients with Relapsed or Refractory Peripheral T/NK Cell or Cutaneous T Cell Lymphoma

    Not recruiting

    2 1 1
    Investigated diseases:
    • Cutaneous T-cell lymphoma
    • Cutaneous T-cell lymphoma refractory
    Investigated drugs:
    • Linperlisib
    Italy

  • Study of Tolinapant with Decitabine and Cedazuridine for Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

    Not recruiting

    1 1 1
    Investigated drugs:
    • Cedazuridine
    • Tolinapant Lactate
    • Decitabine
    France Hungary Italy Poland Spain

  • Study of Pembrolizumab and Cisplatin for Patients with Stage III-IVA Resectable Head and Neck Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Squamous cell carcinoma of head and neck
    Investigated drugs:
    • Cisplatin
    • Pembrolizumab
    Austria Belgium France Germany Hungary Ireland +3

  • Study on Imaging with 89Zr-Atezolizumab to Monitor Immune Responses in Patients with Metastatic Triple Negative Breast Cancer Using Atezolizumab and Drug Combination

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Triple negative breast cancer
    • Breast cancer metastatic
    Investigated drugs:
    • Atezolizumab
    • Paclitaxel Albumin-Bound
    • Carboplatin
    Sweden
Previous Page
1 … 473 474 475 476 477 … 515
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!